Waddell & Associates’s CME Group CME Stock Holding History

Waddell & Associates’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-810	Closed	-$221K	–	460
2025 Q4	$221K	Buy	+810	New	+$220K	0.01%	345

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Waddell & Associates's CME Position: Q1 2026 in Review

Waddell & Associates sold out of CME Group (CME) in Q1 2026, closing a stake of 810 shares — an estimated $221K sold.

Waddell & Associates first reported a position in CME in Q4 2025 and held it in 1 quarter. The position peaked at $221K in Q4 2025. 1,794 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Waddell & Associates reported no remaining CME Group position as of Q1 2026 after selling out during the quarter.
Waddell & Associates sold 810 CME Group shares in Q1 2026, an estimated $221K.
Waddell & Associates first reported a position in CME Group in Q4 2025 and held it in 1 quarter.
Waddell & Associates's CME Group position peaked at $221K in Q4 2025.
1,794 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Waddell & Associates's 13F filing for Q1 2026, filed 11 May 2026.